TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ROP

ROP

ROPER TECHNOLOGIES INC

Next earnings Jul 17, 2026 · consensus $5.34 EPS, $2.12B rev

Last earnings -0.3% on 2026-04-23

Buy
$364.20
▲ +8.78%
$364.20▼ -34.87%
over 1Y
L $314.73H $568.61
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+8.8%
1W+9.6%
1M+8.2%
3M+2.0%
YTD-16.0%
1Y-34.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
C+
Valuation
Overvalued
Filings
Clean
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 25 analysts
Buy

High-quality vertical-software compounder at a fair 23x P/E and ~7% cash-flow yield — own it, but GAAP earnings have stalled.

Revenue $7.90B · FY2025

The read

The fundamentals carry the rating, but the price is rich (~37% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.

Roper is exactly what its MD&A advertises: a diversified roll-up of "market leading businesses that design and develop vertical software" in "defensible niche markets," run by a capital-allocation-first CEO. The quality shows in the numbers — 69.2% gross margin, 28.3% operating margin, and revenue compounding steadily from $4.83B (FY2021) to $7.90B (FY2025), with FY2025 up a healthy +12.3% and operating income up +11.9%. Operating cash flow of $2.54B against trivial capital intensity converts that into ~$2.5B of free cash, a ~7% cash-flow yield on the $34B market cap — the lens that matters most for an amortization-heavy acquirer, and on which 23x P/E looks cheap rather than full.

The catch is the gap between revenue and earnings: net income slipped -0.8% and diluted EPS -1.0% even as revenue grew double digits. The culprits are visible in the data — $898M of D&A (+10.5%) and a 30.6% jump in long-term debt to $8.60B that is raising interest expense. In other words, the acquisition engine is buying revenue and margin, but amortization and leverage are eating the GAAP bottom line. The 7.7% ROE looks weak but is an artifact of a goodwill/intangible-heavy $19.9B equity base, not poor operations; cash returns are far higher.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 12:37 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$4.83B$5.37B$6.18B$7.04B$7.90B
Gross profit$3.41B$3.75B$4.31B$4.88B$5.47B
Operating income$1.24B$1.52B$1.75B$2.00B$2.24B
Net income$1.15B$4.54B$1.38B$1.55B$1.54B
Diluted EPS$10.82$42.55$12.89$14.35$14.20
Net margin23.8%84.6%22.4%22.0%19.4%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$45.8B
EV / EBITDA14.6
EV / Sales5.8
EV / FCF18.4
P / FCF14.8
PEG (trailing)—
Earnings yield4.2%
FCF yield6.8%

Quality & risk

ROIC (est.)6.1%
Free cash flow$2.49B
Total debt$9.30B
Net cash-$9.00B
Altman Z-Score2.58 grey
Piotroski F-Score6/9

Capital returns

Buyback yield1.4%
Dividend yield (est.)1.0%
Shareholder yield2.3%
Shares Δ YoY-4.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Officer / director change2026-05-19

    Annual meeting: shareholders approved board/auditor votes; officer change disclosed

  2. 10-Q Quarterly report2026-05-01

    Q1 2026: continued revenue growth, recurring software model intact

  3. 8-K Earnings results2026-04-23

    Q1 FY2026 results released; double-digit revenue growth continued

  4. DEF 14A Proxy statement2026-04-07

    2026 proxy: board slate, exec comp and auditor up for shareholder vote

  5. 8-K Agreement terminated2026-04-01

    New credit agreement entered, prior one terminated; added debt obligation

  6. 10-K Annual report2026-02-24

    FY2025: revenue +12.3% to $7.9B, but net income and EPS roughly flat

  7. 8-K Earnings results2026-01-27

    FY2025/Q4 results: revenue +12% to $7.9B, EPS roughly flat

  8. 10-Q Quarterly report2025-10-31

    Q3 2025: revenue growth continued, recurring software base steady

  9. 8-K Earnings results2025-10-23

    Q3 2025 earnings released; revenue growth on track

Recent filings

all on EDGAR ↗
S-8Filing2026-07-01open ↗11-KPeriod ending 2025-12-312026-06-22open ↗11-KPeriod ending 2025-12-312026-06-22open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗4Period ending 2026-05-202026-05-21open ↗S-8Filing2026-05-19open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueC
GrowthC
ProfitabilityB+
Financial healthA-
MomentumD
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$229.05

Overvalued -37% vs price

cheapfair valueexpensive

Modified Graham: EPS $14.20 × (8.5 + 1.5 × 5.7% growth) × 0.95 quality = 16.1× multiple. An estimate, not a price target.

314.7352-week561.66
Revenue
$7.90B
+12.3% YoY
Net margin
19.4%
ROE
7.7%
P/E
25.6

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$7.90B+12.3%
Net income$1.54B-0.8%
Gross profit$5.47B+12.2%
Operating income$2.24B+11.9%
Diluted EPS$14.20-1.0%
Cash & equivalents$297M+58.0%
Total assets$34.6B+10.3%
Total liabilities$14.7B+17.9%
Stockholders' equity$19.9B+5.4%
Gross: 69.2%Op.: 28.3%L/E: 0.74x

Frequently asked

Is ROPER TECHNOLOGIES INC (ROP) a buy?
ROP currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. High-quality vertical-software compounder at a fair 23x P/E and ~7% cash-flow yield — own it, but GAAP earnings have stalled.
What is ROP's fair value?
A Modified-Graham model based on ROP's SEC fundamentals estimates a fair value of about $229.05. It is an estimate from reported earnings, not a price target.
Is ROP overvalued or undervalued?
Against a Modified-Graham fair-value estimate, ROP currently appears overvalued relative to its SEC-grounded earnings power.
What is ROPER TECHNOLOGIES INC's quality score?
ROP scores 64.97065711544701/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000882835, latest 10-Q filed 2026-05-01) · EODHD · Proprietary analysis · as of 6/21/2026, 4:37:48 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-05-20
ESTEVES IRENE M
Director
Award1.19K
2026-05-20
ARCHAMBEAU SHELLYE L
Director
Award1.19K
2026-05-20
Joyce Thomas Patrick JR
Director
Award1.19K
2026-05-20
BRINKLEY AMY WOODS
Director
Award1.19K
2026-05-20
JOHNSON ROBERT D
Director
Award1.19K
2026-05-20
Murphy John Francis
Director
Award1.19K
2026-05-20
Thatcher Laura G
Director
Award1.19K
2026-05-20
WALLMAN RICHARD F
Director
Award1.19K

Dividends

Quarterly
Yield (TTM)
1.2%
Annual / share
$4.38
Last ex-date
2026-07-08
Last amount
$0.91
ex 2026-07-08paid 2026-07-22$0.91
ex 2026-04-06paid 2026-04-22$0.91
ex 2026-01-02paid 2026-01-16$0.91
ex 2025-10-03paid 2025-10-17$0.83
ex 2025-07-08paid 2025-07-22$0.83
ex 2025-04-04paid 2025-04-22$0.83

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-23Beat +2.6% est▼ -0.27%8-K ↗
2026-01-27Beat +0.4% est▼ -9.64%8-K ↗
2025-10-23—▼ -5.70%8-K ↗
2025-07-21—▲ +1.31%8-K ↗
2025-04-28—▼ -1.03%8-K ↗
2025-01-30—▲ +5.08%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

1 buy · 4 sells · 2 members · last 180d

−$48.5K net soldlast trade 51d ago
$8.00K bought$56.5K sold
2026-06-08Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-05-08Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2026-04-07Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2026-03-30Jared MoskowitzSell$1.00K–$15.0KPTR ↗
2026-03-09Gilbert CisnerosSell$15.0K–$50.0KPTR ↗
2025-09-12Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainBuy$1.00K–$15.0KPTR ↗
2025-04-28Rob BresnahanSell$1.00K–$15.0KPTR ↗
2024-08-21Jared MoskowitzBuy$1.00K–$15.0KPTR ↗
2024-08-06Jared MoskowitzBuy$1.00K–$15.0KPTR ↗
2024-01-22Jared MoskowitzBuy$1.00K–$15.0KPTR ↗
2023-06-06Zoe LofgrenSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Roche (SWX:ROP) Stock May Still Be A Bargain On A 32% RunBullish
finance.yahoo.com· 2026-07-02
Roche (SWX:ROP) Launches AXELIOS 1 As Enspryng Review And Excalipoint Deal Expand ReachBullish
finance.yahoo.com· 2026-07-01
Roper Technologies schedules second quarter 2026 financial results conference callBullish
finance.yahoo.com· 2026-07-01
Roper Technologies schedules second quarter 2026 financial results conference callBullish
globenewswire.com· 2026-07-01
ROP or JKHY: Which Is the Better Value Stock Right Now?Bullish
finance.yahoo.com· 2026-06-30
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)Bullish
finance.yahoo.com· 2026-06-30

Vs Information Technology peers

compare →

163 tracked peers · median

TENK Score65 vs 62
Revenue growth12.3% vs 15.5%
Net margin19.4% vs 10.2%
Return on equity7.7% vs 9.1%
P/E25.6 vs 45.4
Peers
QLYSGENCRUSACIWFFIVZMFSLRAPH

News sentiment

EODHD · 36d
Bullish
+0.09
vs typical · 58 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.